logo
Secondary mitral and tricuspid regurgitation accompanying left ventricular systolic dysfunction: Is it important, and how is it treated?
Reperfusion in waiting: What queue should we join?
Demise of the routine electrophysiologic study for survivors of life-threatening ventricular arrhythmias
The pediatric randomized carvedilol trial in children with chronic heart failure: Rationale and design
Risk of sudden versus nonsudden cardiac death in patients with coronary artery disease
Utilization and outcomes of the implantable cardioverter defibrillator, 1987 to 1995
Life after a ventricular arrhythmia
Trends in hospital treatment of ventricular arrhythmias among Medicare beneficiaries, 1985 to 1995
Overview of randomized trials of antiarrhythmic drugs and devices for the prevention of sudden cardiac death
Management of ventricular arrhythmias in diverse populations in California
Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator
High-sensitivity C-reactive protein in the prediction of coronary events in patients with premature coronary artery disease
How long is too long? Association of time delay to successful reperfusion and ventricular function outcome in acute myocardial infarction: The case for thrombolytic therapy before planned angioplasty for acute myocardial infarction
Inhospital outcome of acute myocardial infarction in patients with prior coronary artery bypass surgery
Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: The ACUTE II study
Prognostic value of baseline electrophysiology studies in patients with sustained ventricular tachyarrhythmia: The Antiarrhythmics Versus Implantable Defibrillators (AVID) trial
Association of the human minK gene 38G allele with atrial fibrillation: Evidence of possible genetic control on the pathogenesis of atrial fibrillation
Greater pathogen burden but not elevated C-reactive protein increases the risk of clinical restenosis after percutaneous coronary intervention
Relationship between activated clotting time during percutaneous intervention and subsequent bleeding complications
Effects of sibutramine on ventricular dimensions and heart valves in obese patients during weight reduction
Determinants of tissue Doppler measures of regional diastolic function during dobutamine stress echocardiography
Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction
Is cardiovascular remodeling in patients with essential hypertension related to more than high blood pressure? A LIFE substudy
Impact of disease activity on left ventricular performance in patients with acromegaly
Emergency endovascular interventions for ruptured thoracic and abdominal aortic aneurysms
Highlights from the American College of Cardiology Annual Scientific Sessions 2002: March 17 to 20, 2002